Kolexia
Margery Jacques
Médecine générale
Service de santé des armées françaises
Paris, France
128 Activités
724 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Mésothéliome Mésothéliome malin Carcinome pulmonaire non à petites cellules Tumeurs de la plèvre Carcinome pulmonaire à petites cellules Maladies pulmonaires Hypertension artérielle Tuberculose

Industries

A+A
2 collaboration(s)
Dernière en 2018
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

️ Le 1er janvier... - Service de santé des armées - SSA
Facebook   01 janvier 2024
Lot-et-Garonne: un infirmier militaire de 33 ans meurt lors d'un ...
BFMTV   30 septembre 2023
MAPS: A Phase II-III Randomized Trial Pemetrexed-Cisplatin Chemotherapy With or Without Bevacizumab (Avastin), 15 mg/kg, for Malignant Pleural Mesothelioma (MPM)
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   10 mars 2023
LUCSO: LUng Cancer Screening With Low-dose Computed Tomography in a Population Exposed to Occupational Lung Carcinogens
Essai Clinique (Centre Hospitalier Intercommunal Creteil)   08 février 2023
A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial.
International journal of cancer   16 mars 2022
Single-centre experience of transbronchial cryobiopsy as a first choice method for the diagnosis of interstitial lung disease.
Indian journal of thoracic and cardiovascular surgery   23 janvier 2022
Tailoring maintenance chemotherapy upon response to induction chemotherapy as compared with pemetrexed continuation maintenance in advanced non-squamous NSCLC patients: Results of the IFCT-GFPC-1101 multicenter randomized phase III trial.
Lung cancer (Amsterdam, Netherlands)   30 novembre 2021
Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial.
European journal of cancer (Oxford, England : 1990)   06 septembre 2020
Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care.
Clinical lung cancer   23 mai 2020
Assessment of preoperative noninvasive ventilation before lung cancer surgery: The preOVNI randomized controlled study.
The Journal of thoracic and cardiovascular surgery   23 novembre 2019